ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intranasal Drug Delivery System Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-26A14080
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intranasal Drug Delivery System Market Research Report 2023
BUY CHAPTERS

Global Intranasal Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-26A14080
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aptar Pharma
Nemera
Teleflex
Johnson & Johnson
GlaxoSmithKline PLC
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd
Astrazeneca plc
Becton
BD
Novartis
Vectura Group plc
Zeteo Medical
Johnson & Johnson
H&T Presspart Manufacturing Ltd
Bio-Legacy Evaluative Group

Intranasal Drug Delivery System Market Size

The global market for Intranasal Drug Delivery System was valued at US$ 2853 million in the year 2024 and is projected to reach a revised size of US$ 4595 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Intranasal Drug Delivery System Market

Intranasal Drug Delivery System Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Intranasal Drug Delivery System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An intranasal drug delivery system is a formulation or device that delivers drugs through the nasal cavity. It takes advantage of the high permeability and rich vascularity of the nasal mucosa to enable the drug to be rapidly absorbed into the blood circulation, thereby achieving local treatment or systemic effects. This method of administration avoids the first-pass effect, improves the bioavailability of the drug, and is an effective alternative for patients who are not suitable for oral or injection administration. Intranasal drug delivery systems can be used to treat a variety of diseases, including but not limited to allergic rhinitis, migraines, and situations requiring emergency treatment such as pain management and certain types of epileptic seizures. They are also being studied for vaccination and the treatment of neurological diseases.
Intranasal drug delivery systems are currently in a rapid development stage, thanks to their non-invasiveness, convenience and potential to improve patient compliance. With technological advances, such systems are not only used for local treatments such as allergic rhinitis, but have also expanded to the treatment of systemic diseases, including vaccination and chronic disease management. In recent years, innovations in intranasal drug delivery systems have focused on improving drug bioavailability, controlling release rates, and enhancing targeting of specific disease targets. In addition, the development of nanotechnology and particulate carriers has provided new possibilities for intranasal delivery, allowing large molecule drugs such as proteins and peptides to be effectively absorbed through the nasal cavity. Products on the market are constantly being introduced, and research is also continuing to explore how to overcome the physiological barriers of the nasal cavity to achieve more efficient and safe drug delivery, meet unmet medical needs, and open up new application areas. Especially during the COVID-19 pandemic, research on the nasal cavity as a vaccine delivery route has been significantly accelerated, showing broad prospects in this field.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intranasal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug Delivery System.
The Intranasal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intranasal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intranasal Drug Delivery System Market Report

Report Metric Details
Report Name Intranasal Drug Delivery System Market
Accounted market size in year US$ 2853 million
Forecasted market size in 2031 US$ 4595 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Home Care
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aptar Pharma, Nemera, Teleflex, Bio-Legacy Evaluative Group, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC, H&T Presspart Manufacturing Ltd., AstraZeneca Plc, Becton, BD, Novartis AG, Vectura Group Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intranasal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intranasal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Intranasal Drug Delivery System Market growing?

Ans: The Intranasal Drug Delivery System Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Intranasal Drug Delivery System Market size in 2031?

Ans: The Intranasal Drug Delivery System Market size in 2031 will be US$ 4595 million.

Who are the main players in the Intranasal Drug Delivery System Market report?

Ans: The main players in the Intranasal Drug Delivery System Market are Aptar Pharma, Nemera, Teleflex, Bio-Legacy Evaluative Group, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC, H&T Presspart Manufacturing Ltd., AstraZeneca Plc, Becton, BD, Novartis AG, Vectura Group Plc

What are the Application segmentation covered in the Intranasal Drug Delivery System Market report?

Ans: The Applications covered in the Intranasal Drug Delivery System Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Intranasal Drug Delivery System Market report?

Ans: The Types covered in the Intranasal Drug Delivery System Market report are Nasal Drops, Nasal Sprays, Nasal Gels, Nasal Suspensions and Emulsion, Nasal Powders

Recommended Reports

Nasal Drug Delivery

Allergic Rhinitis Markets

Drug Delivery Systems

1 Intranasal Drug Delivery System Market Overview
1.1 Product Definition
1.2 Intranasal Drug Delivery System by Type
1.2.1 Global Intranasal Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nasal Drops
1.2.3 Nasal Sprays
1.2.4 Nasal Gels
1.2.5 Nasal Suspensions and Emulsion
1.2.6 Nasal Powders
1.3 Intranasal Drug Delivery System by Application
1.3.1 Global Intranasal Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Intranasal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug Delivery System Revenue 2020-2031
1.4.2 Global Intranasal Drug Delivery System Sales 2020-2031
1.4.3 Global Intranasal Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intranasal Drug Delivery System Market Competition by Manufacturers
2.1 Global Intranasal Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intranasal Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intranasal Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intranasal Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intranasal Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Intranasal Drug Delivery System, Date of Enter into This Industry
2.8 Global Intranasal Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Intranasal Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intranasal Drug Delivery System Players Market Share by Revenue
2.8.3 Global Intranasal Drug Delivery System Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intranasal Drug Delivery System Market Scenario by Region
3.1 Global Intranasal Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intranasal Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Intranasal Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Intranasal Drug Delivery System Sales by Region: 2026-2031
3.3 Global Intranasal Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Intranasal Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Intranasal Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Intranasal Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Intranasal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intranasal Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Intranasal Drug Delivery System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intranasal Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intranasal Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Intranasal Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Intranasal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intranasal Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Intranasal Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intranasal Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intranasal Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Intranasal Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intranasal Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intranasal Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intranasal Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Intranasal Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Intranasal Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Intranasal Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Intranasal Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Intranasal Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Intranasal Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Intranasal Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Intranasal Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intranasal Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Intranasal Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Intranasal Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Intranasal Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Intranasal Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Intranasal Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Intranasal Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Intranasal Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Intranasal Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aptar Pharma
6.1.1 Aptar Pharma Company Information
6.1.2 Aptar Pharma Description and Business Overview
6.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aptar Pharma Intranasal Drug Delivery System Product Portfolio
6.1.5 Aptar Pharma Recent Developments/Updates
6.2 Nemera
6.2.1 Nemera Company Information
6.2.2 Nemera Description and Business Overview
6.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nemera Intranasal Drug Delivery System Product Portfolio
6.2.5 Nemera Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Company Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teleflex Intranasal Drug Delivery System Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Bio-Legacy Evaluative Group
6.4.1 Bio-Legacy Evaluative Group Company Information
6.4.2 Bio-Legacy Evaluative Group Description and Business Overview
6.4.3 Bio-Legacy Evaluative Group Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bio-Legacy Evaluative Group Intranasal Drug Delivery System Product Portfolio
6.4.5 Bio-Legacy Evaluative Group Recent Developments/Updates
6.5 Zeteo Medical
6.5.1 Zeteo Medical Company Information
6.5.2 Zeteo Medical Description and Business Overview
6.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zeteo Medical Intranasal Drug Delivery System Product Portfolio
6.5.5 Zeteo Medical Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Intranasal Drug Delivery System Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GlaxoSmithKline Plc
6.7.1 GlaxoSmithKline Plc Company Information
6.7.2 GlaxoSmithKline Plc Description and Business Overview
6.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Product Portfolio
6.7.5 GlaxoSmithKline Plc Recent Developments/Updates
6.8 Aegis Therapeutics LLC
6.8.1 Aegis Therapeutics LLC Company Information
6.8.2 Aegis Therapeutics LLC Description and Business Overview
6.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Product Portfolio
6.8.5 Aegis Therapeutics LLC Recent Developments/Updates
6.9 H&T Presspart Manufacturing Ltd.
6.9.1 H&T Presspart Manufacturing Ltd. Company Information
6.9.2 H&T Presspart Manufacturing Ltd. Description and Business Overview
6.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Portfolio
6.9.5 H&T Presspart Manufacturing Ltd. Recent Developments/Updates
6.10 AstraZeneca Plc
6.10.1 AstraZeneca Plc Company Information
6.10.2 AstraZeneca Plc Description and Business Overview
6.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AstraZeneca Plc Intranasal Drug Delivery System Product Portfolio
6.10.5 AstraZeneca Plc Recent Developments/Updates
6.11 Becton
6.11.1 Becton Company Information
6.11.2 Becton Description and Business Overview
6.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Becton Intranasal Drug Delivery System Product Portfolio
6.11.5 Becton Recent Developments/Updates
6.12 BD
6.12.1 BD Company Information
6.12.2 BD Description and Business Overview
6.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BD Intranasal Drug Delivery System Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Novartis AG
6.13.1 Novartis AG Company Information
6.13.2 Novartis AG Description and Business Overview
6.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novartis AG Intranasal Drug Delivery System Product Portfolio
6.13.5 Novartis AG Recent Developments/Updates
6.14 Vectura Group Plc
6.14.1 Vectura Group Plc Company Information
6.14.2 Vectura Group Plc Description and Business Overview
6.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vectura Group Plc Intranasal Drug Delivery System Product Portfolio
6.14.5 Vectura Group Plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intranasal Drug Delivery System Industry Chain Analysis
7.2 Intranasal Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug Delivery System Production Mode & Process Analysis
7.4 Intranasal Drug Delivery System Sales and Marketing
7.4.1 Intranasal Drug Delivery System Sales Channels
7.4.2 Intranasal Drug Delivery System Distributors
7.5 Intranasal Drug Delivery System Customer Analysis
8 Intranasal Drug Delivery System Market Dynamics
8.1 Intranasal Drug Delivery System Industry Trends
8.2 Intranasal Drug Delivery System Market Drivers
8.3 Intranasal Drug Delivery System Market Challenges
8.4 Intranasal Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aptar Pharma
Nemera
Teleflex
Johnson & Johnson
GlaxoSmithKline PLC
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd
Astrazeneca plc
Becton
BD
Novartis
Vectura Group plc
Zeteo Medical
Johnson & Johnson
H&T Presspart Manufacturing Ltd
Bio-Legacy Evaluative Group
List of Tables
 Table 1. Global Intranasal Drug Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intranasal Drug Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intranasal Drug Delivery System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intranasal Drug Delivery System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intranasal Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intranasal Drug Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intranasal Drug Delivery System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intranasal Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intranasal Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intranasal Drug Delivery System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intranasal Drug Delivery System, Product Type & Application
 Table 12. Global Key Manufacturers of Intranasal Drug Delivery System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intranasal Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intranasal Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intranasal Drug Delivery System Sales Market Share by Region (2020-2025)
 Table 19. Global Intranasal Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intranasal Drug Delivery System Sales Market Share by Region (2026-2031)
 Table 21. Global Intranasal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intranasal Drug Delivery System Revenue Market Share by Region (2020-2025)
 Table 23. Global Intranasal Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intranasal Drug Delivery System Revenue Market Share by Region (2026-2031)
 Table 25. North America Intranasal Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intranasal Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intranasal Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intranasal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intranasal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intranasal Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intranasal Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intranasal Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intranasal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intranasal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intranasal Drug Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intranasal Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intranasal Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intranasal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intranasal Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intranasal Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intranasal Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intranasal Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intranasal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intranasal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intranasal Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intranasal Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intranasal Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intranasal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intranasal Drug Delivery System Sales (K Units) by Type (2020-2025)
 Table 51. Global Intranasal Drug Delivery System Sales (K Units) by Type (2026-2031)
 Table 52. Global Intranasal Drug Delivery System Sales Market Share by Type (2020-2025)
 Table 53. Global Intranasal Drug Delivery System Sales Market Share by Type (2026-2031)
 Table 54. Global Intranasal Drug Delivery System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intranasal Drug Delivery System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intranasal Drug Delivery System Revenue Market Share by Type (2020-2025)
 Table 57. Global Intranasal Drug Delivery System Revenue Market Share by Type (2026-2031)
 Table 58. Global Intranasal Drug Delivery System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intranasal Drug Delivery System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intranasal Drug Delivery System Sales (K Units) by Application (2020-2025)
 Table 61. Global Intranasal Drug Delivery System Sales (K Units) by Application (2026-2031)
 Table 62. Global Intranasal Drug Delivery System Sales Market Share by Application (2020-2025)
 Table 63. Global Intranasal Drug Delivery System Sales Market Share by Application (2026-2031)
 Table 64. Global Intranasal Drug Delivery System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intranasal Drug Delivery System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intranasal Drug Delivery System Revenue Market Share by Application (2020-2025)
 Table 67. Global Intranasal Drug Delivery System Revenue Market Share by Application (2026-2031)
 Table 68. Global Intranasal Drug Delivery System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intranasal Drug Delivery System Price (US$/Unit) by Application (2026-2031)
 Table 70. Aptar Pharma Company Information
 Table 71. Aptar Pharma Description and Business Overview
 Table 72. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Aptar Pharma Intranasal Drug Delivery System Product
 Table 74. Aptar Pharma Recent Developments/Updates
 Table 75. Nemera Company Information
 Table 76. Nemera Description and Business Overview
 Table 77. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Nemera Intranasal Drug Delivery System Product
 Table 79. Nemera Recent Developments/Updates
 Table 80. Teleflex Company Information
 Table 81. Teleflex Description and Business Overview
 Table 82. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teleflex Intranasal Drug Delivery System Product
 Table 84. Teleflex Recent Developments/Updates
 Table 85. Bio-Legacy Evaluative Group Company Information
 Table 86. Bio-Legacy Evaluative Group Description and Business Overview
 Table 87. Bio-Legacy Evaluative Group Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bio-Legacy Evaluative Group Intranasal Drug Delivery System Product
 Table 89. Bio-Legacy Evaluative Group Recent Developments/Updates
 Table 90. Zeteo Medical Company Information
 Table 91. Zeteo Medical Description and Business Overview
 Table 92. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zeteo Medical Intranasal Drug Delivery System Product
 Table 94. Zeteo Medical Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Intranasal Drug Delivery System Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. GlaxoSmithKline Plc Company Information
 Table 101. GlaxoSmithKline Plc Description and Business Overview
 Table 102. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline Plc Intranasal Drug Delivery System Product
 Table 104. GlaxoSmithKline Plc Recent Developments/Updates
 Table 105. Aegis Therapeutics LLC Company Information
 Table 106. Aegis Therapeutics LLC Description and Business Overview
 Table 107. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Aegis Therapeutics LLC Intranasal Drug Delivery System Product
 Table 109. Aegis Therapeutics LLC Recent Developments/Updates
 Table 110. H&T Presspart Manufacturing Ltd. Company Information
 Table 111. H&T Presspart Manufacturing Ltd. Description and Business Overview
 Table 112. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product
 Table 114. H&T Presspart Manufacturing Ltd. Recent Developments/Updates
 Table 115. AstraZeneca Plc Company Information
 Table 116. AstraZeneca Plc Description and Business Overview
 Table 117. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. AstraZeneca Plc Intranasal Drug Delivery System Product
 Table 119. AstraZeneca Plc Recent Developments/Updates
 Table 120. Becton Company Information
 Table 121. Becton Description and Business Overview
 Table 122. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Becton Intranasal Drug Delivery System Product
 Table 124. Becton Recent Developments/Updates
 Table 125. BD Company Information
 Table 126. BD Description and Business Overview
 Table 127. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BD Intranasal Drug Delivery System Product
 Table 129. BD Recent Developments/Updates
 Table 130. Novartis AG Company Information
 Table 131. Novartis AG Description and Business Overview
 Table 132. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Novartis AG Intranasal Drug Delivery System Product
 Table 134. Novartis AG Recent Developments/Updates
 Table 135. Vectura Group Plc Company Information
 Table 136. Vectura Group Plc Description and Business Overview
 Table 137. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Vectura Group Plc Intranasal Drug Delivery System Product
 Table 139. Vectura Group Plc Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Intranasal Drug Delivery System Distributors List
 Table 143. Intranasal Drug Delivery System Customers List
 Table 144. Intranasal Drug Delivery System Market Trends
 Table 145. Intranasal Drug Delivery System Market Drivers
 Table 146. Intranasal Drug Delivery System Market Challenges
 Table 147. Intranasal Drug Delivery System Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intranasal Drug Delivery System
 Figure 2. Global Intranasal Drug Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intranasal Drug Delivery System Market Share by Type: 2024 & 2031
 Figure 4. Nasal Drops Product Picture
 Figure 5. Nasal Sprays Product Picture
 Figure 6. Nasal Gels Product Picture
 Figure 7. Nasal Suspensions and Emulsion Product Picture
 Figure 8. Nasal Powders Product Picture
 Figure 9. Global Intranasal Drug Delivery System Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Intranasal Drug Delivery System Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Home Care
 Figure 14. Others
 Figure 15. Global Intranasal Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Intranasal Drug Delivery System Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Intranasal Drug Delivery System Sales (2020-2031) & (K Units)
 Figure 18. Global Intranasal Drug Delivery System Average Price (US$/Unit) & (2020-2031)
 Figure 19. Intranasal Drug Delivery System Report Years Considered
 Figure 20. Intranasal Drug Delivery System Sales Share by Manufacturers in 2024
 Figure 21. Global Intranasal Drug Delivery System Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Intranasal Drug Delivery System Players: Market Share by Revenue in Intranasal Drug Delivery System in 2024
 Figure 23. Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Intranasal Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Intranasal Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 26. North America Intranasal Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Intranasal Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 30. Europe Intranasal Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Intranasal Drug Delivery System Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Intranasal Drug Delivery System Revenue Market Share by Region (2020-2031)
 Figure 38. China Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Intranasal Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Intranasal Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Intranasal Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Intranasal Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Intranasal Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Intranasal Drug Delivery System by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Intranasal Drug Delivery System by Type (2020-2031)
 Figure 60. Global Intranasal Drug Delivery System Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Intranasal Drug Delivery System by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Intranasal Drug Delivery System by Application (2020-2031)
 Figure 63. Global Intranasal Drug Delivery System Price (US$/Unit) by Application (2020-2031)
 Figure 64. Intranasal Drug Delivery System Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Intranasal Drug Delivery Market Research Report 2024
Global Nasal Delivery Market Research Report 2024
Nasal Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasal Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dental Drug Delivery System Market Insights Forecast to 2030
Unit Dose Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Smart Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasal Drug Nebulizer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Electronic Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasal Antihistamines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Needle Free Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Integrated Diagnostic System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alternative Drug Delivery Systems Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions